IP Verse

An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases

Patent No. EP3574907 (titled "An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases") was filed by Kandy Therapeutics on May 16, 2016. The application was issued on Aug 23, 2023.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
AERA	May 23, 2024	-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Feb 6, 2025
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Feb 6, 2025
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Oct 25, 2024
Decision revoking the European patent
Oct 25, 2024
Decision revoking the European patent
Oct 22, 2024
(Electronic) Receipt
Oct 22, 2024
Letter accompanying subsequently filed items
Oct 22, 2024
Request for revocation of patent
Jun 7, 2024
Communication of a notice of opposition and request to file observations
Jun 7, 2024
Notice of further oppositions to opponent(s)
May 29, 2024
Communication of a notice of opposition - first information to patent proprietor
May 23, 2024
(Electronic) Receipt
May 23, 2024
Citation in opposition procedure - 001
May 23, 2024
Citation in opposition procedure - 002
May 23, 2024
Citation in opposition procedure - 003
May 23, 2024
Citation in opposition procedure - 004
May 23, 2024
Citation in opposition procedure - 005
May 23, 2024
Citation in opposition procedure - 006
May 23, 2024
Citation in opposition procedure - 007
May 23, 2024
Consolidated list of cited opposition documents
May 23, 2024
Letter accompanying subsequently filed items
May 23, 2024
Notice of opposition
Sep 5, 2023
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 27, 2023
Decision to grant a European patent
Jul 12, 2023
(Electronic) Receipt
Jul 12, 2023
Filing of the translations of the claims
Jul 12, 2023
French translation of claims
Jul 12, 2023
German translation of the claims
Jul 12, 2023
Letter accompanying subsequently filed items
Mar 20, 2023
Annex to the communication about intention to grant a European patent
Mar 20, 2023
Bibliographic data of the European patent application
Mar 20, 2023
Communication about intention to grant a European patent
Mar 20, 2023
Intention to grant (signatures)
Mar 20, 2023
Text intended for grant (clean copy)
Mar 20, 2023
Text intended for grant (version for approval)
Sep 2, 2022
(Electronic) Receipt
Sep 2, 2022
Amended claims with annotations
Sep 2, 2022
Claims
Sep 2, 2022
Letter accompanying subsequently filed items
Sep 2, 2022
Reply to communication from the Examining Division
Aug 11, 2022
Grant of extension of time limit (examination procedure)
Aug 8, 2022
(Electronic) Receipt
Aug 8, 2022
Letter accompanying subsequently filed items
Aug 8, 2022
Request for extension of time limit to communication from the Examining Division
Jun 2, 2022
Annex to the communication
Jun 2, 2022
Communication from the Examining Division
May 12, 2021
Communication of the registration of a transfer or change of name and/or address
May 5, 2021
(Electronic) Receipt
May 5, 2021
Annexes in respect of a client data request
May 5, 2021
Letter accompanying subsequently filed items
May 5, 2021
Miscellaneous requests concerning client data
Mar 22, 2021
Indication of deficiencies in a request for registering a transfer of rights and invitation to correct them
Feb 22, 2021
(Electronic) Receipt
Feb 22, 2021
Letter accompanying subsequently filed items
Feb 22, 2021
Reply to communication from the Examining Division
Jan 22, 2021
(Electronic) Receipt
Jan 22, 2021
Annexes in respect of a client data request
Jan 22, 2021
Letter accompanying subsequently filed items
Jan 22, 2021
Submission concerning a transfer of rights (applicant)
Dec 16, 2020
Grant of extension of time limit (examination procedure)
Dec 11, 2020
(Electronic) Receipt
Dec 11, 2020
Letter accompanying subsequently filed items
Dec 11, 2020
Request for extension of time limit to communication from the Examining Division
Aug 28, 2020
Annex to the communication
Aug 28, 2020
Communication from the Examining Division
Aug 24, 2020
Examination started
Jun 15, 2020
Refund of fees
Jun 2, 2020
(Electronic) Receipt
Jun 2, 2020
Amended claims filed after receipt of (European) search report
Jun 2, 2020
Amended claims with annotations
Jun 2, 2020
Amended description filed after receipt of (European) search report
Jun 2, 2020
Amended description with annotations
Jun 2, 2020
Amendments received before examination
Jun 2, 2020
Letter accompanying subsequently filed items
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jun 2, 2020
Non-patent literature cited during the examination procedure
Jan 20, 2020
Document concerning representation
Dec 9, 2019
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Nov 22, 2019
Submission concerning representation
Nov 6, 2019
Notification of forthcoming publication
Oct 11, 2019
Refund of fees
Oct 2, 2019
Communication regarding the transmission of the European search report
Oct 2, 2019
European search opinion
Oct 2, 2019
European search report
Oct 2, 2019
Information on Search Strategy
Sep 25, 2019
Search started
Sep 4, 2019
Communication to designated inventor
Jul 12, 2019
Abstract
Jul 12, 2019
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jul 12, 2019
Annex
Jul 12, 2019
Claims
Jul 12, 2019
Description
Jul 12, 2019
Designation of inventor
Jul 12, 2019
Matter concerning the application
Jul 12, 2019
Request for grant of a European patent
Dec 12, 2016
Priority document (electronically transmitted)

EP3574907

KANDY THERAPEUTICS

Application Number: EP19186140A
Filing Date: May 16, 2016
Status: Revoked; Feb 7, 2025
Publication Date: Aug 23, 2023
External Links: Slate, EP3574907B1, Google Patents